Skip to content
Quant500 - Quantitative Analysis
Search ticker or company...
ES | EN

Company Profile: HCA Healthcare, Inc. (HCA)

HCA insider trades (13 months) →

$462.86 −1.04% vs. previous close · Market cap $96.69B

Quant500 Scores
Momentum
4.2/10
Value
5.8/10
Growth
4.3/10
Quality
-
Multifactor
-

Market and Valuation

Price & Market

Prev Close Price:$467.73
Open:$463.72
Day's Low:$460.68
Day's High:$470.36
Bid / Ask:-
Market Cap:96.69B
Enterprise Value:152.59B

52-Week Range

52-Week Low:$353.99
52-Week High:$556.52
Current position in 52-week range
52w Low-52w High
50-Day Avg:$438.18
200-Day Avg:$444.31

Volume

Volume Today:987,243
Avg Volume (3m):1,320,331
Avg Volume (10d):1,469,190
52-Week Change:-0.84%
vs S&P 500, 52 weeks:-
Beta:1.10

Valuation Multiples

P/E (trailing):15.36

Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 29, 2026. The P/E is the price divided by that EPS.

P/E (forward):14.79
PEG Ratio:1.42
Price / Book:-
Price / Sales (TTM):1.23
EV / Revenue:1.94
EV / EBITDA:9.66

Dividends

Current yield:0.67%
Annual Dividend Rate:$3.12
Dividend Trailing:$3.06
Yield Trailing:0.65%
5-Year Avg Yield:0.77%
Payout Ratio:10.15%
Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-
Fiscal Year (Next):-

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):78.70B
Gross Profit:33.65B
EBITDA:15.79B
Net Income (TTM):6.78B
Rev Growth (YoY):+3.60%
Earnings Growth (YoY):+4.50%
Quarterly earnings growth (YoY):-3.90%

Margins

Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-

Per Share

EPS Trailing (TTM):$30.14

Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 29, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$31.29
Revenue Per Share:$355.54
Cash Per Share:-
Book Value:$-38.30
Last Dividend:-
Ex-Dividend Date:-
Last Split:-

Balance Sheet & Liquidity

Total cash:1.02B
Total Debt:52.43B
Net Debt (Debt - Cash):51.41B
Debt / Equity:-
Current Ratio:0.82
Quick Ratio:0.63

Cash Flows

Operating Cash Flow:11.17B
Free Cash Flow (FCF):3.94B
FCF Yield (FCF / Market Cap):-
Enterprise Value:152.59B
EV / Revenue:1.94
EV / EBITDA:9.66

Profitability

ROE (Return on Equity):-
ROA (Return on Assets):12.23%
P/E (trailing):15.36
P/E (forward):14.79
Price / Book:-
PEG Ratio:1.42
52-Week Change:-0.84%
S&P 500 change, 52 weeks:+11.37%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$30.14

Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 29, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$31.29
P/E (forward):14.79
PEG Ratio:1.42

Growth and Margins

Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-

Per Share

Revenue Per Share:$355.54
Cash Per Share:-
Book Value:$-38.30

Cash Flows (TTM)

Free Cash Flow:3.94B
Operating Cash Flow:11.17B
EBITDA:15.79B
Total Revenue (TTM):78.70B
Net Income (TTM):6.78B
Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter Period Actual EPS Estimated EPS Difference Surprise % Currency

Ownership Structure

Ownership Distribution

% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:208,892,500
Float (free shares):136,705,519
Short interest (shares):4,906,014
Short % of float:-
Short Ratio (days to cover):3.70
Short interest, prior month:-
Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization Report Date % Shares No. Shares Value (USD) Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund Report Date % Shares No. Shares Value (USD) Change %

Recent Insider Trades

Executive / Insider Title Date Action Shares

Options Chain

CALLS

StrikeLastBidAskVol.O.I.IV

PUTS

StrikeLastBidAskVol.O.I.IV

HCA Healthcare, Inc. (HCA) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type Date Official link
8-K2026-11-02View filing ↗
8-K2026-10-27View filing ↗
8-K2026-07-29View filing ↗
10-Q2026-07-28View filing ↗
8-K2026-07-24View filing ↗
8-K2026-07-14View filing ↗
8-K2026-06-18View filing ↗
8-K2026-04-30View filing ↗
10-Q2026-04-29View filing ↗
8-K2026-04-24View filing ↗

Company and Executive Profile

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

General Information

Headquarters:United States
City:Nashville
Employees:230,000
Sector:Healthcare
Industry:Medical Care Facilities
Website:-

Key Executives

NameTitleAgeTotal pay
Mr. Samuel N. HazenCEO & Director657.53M
Mr. Michael A. MarksCFO & Executive VP553.49M
Mr. Jon Mack FosterExecutive VP & COO633.76M
Mr. Michael R. McAleveyExecutive VP and Chief Legal & Administrative Officer613.17M
Dr. Michael S. Cuffe M.B.A., M.D.Executive Officer593.16M
Dr. Thomas F. Frist Jr., M.D.Founder & Chairman Emeritus8617,973
Mr. Christopher F. WyattSenior VP, Principal Accounting Officer & Controller47-
Mr. Chad J. WassermanSenior VP & Chief Information Officer--

You have seen the engine room

A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.

No card. No spam.

HCA Healthcare, Inc. (HCA): Quantitative Analysis

HCA Healthcare, Inc. (HCA) — Healthcare — Medical Care Facilities. HCA is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, HCA has returned −0.4% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.

Its strongest factor is value (Z 0.50, ranked 95 of 489); its weakest is momentum (Z -0.51, ranked 331 of 494). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

FactorZ-ScoreRank
Momentum-0.505331 of 494 ↑16
Value0.49595 of 489
Growth-0.402380 of 489

Market data

MetricValue
Price$462.86
Market Cap96.69B
P/E15.36
Revenue (last 12 months)78.70B
Book value per share$-38.30
52-week range$353.99 – $556.52
Dividend yield0.67%
Beta1.10
Average volume1,320,331
Shares outstanding208.89M
Short interest (% of float)3.63% (as of Oct 15, 2026)

When does HCA report earnings? 12 of its last 12, before the open →

What are HCA insiders doing? 68 transactions filed with the SEC, of them 7 sells, the last one on Oct 29, 2026 →

HCA latest SEC filings

Filing dates on EDGAR, the SEC's public registry. All HCA filings on EDGAR.

Guides: How to read a Quant500 company page · What the S&P 500 is · P/E ratio explained · 10-K, 10-Q and 8-K · all guides

Frequently asked questions about HCA Healthcare (HCA)

When does HCA Healthcare report earnings?

HCA Healthcare has no announced date in the Nasdaq public calendar checked (Nov 3, 2026 to Dec 7, 2026). Of its last 12 earnings announcements: 12 before the open (SEC filings through Oct 27, 2026). HCA earnings dates and times, quarter by quarter →

What is HCA Healthcare's P/E ratio?

HCA Healthcare's P/E (price over earnings per share for the last twelve months) is 15.4 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Sep 30, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: HCA Healthcare is below its sector median. Healthcare stocks, company by company →

Have HCA Healthcare insiders bought or sold shares?

SEC Form 4 shows no open-market purchase of HCA Healthcare shares from August 2025 through Nov 3, 2026. The latest sale was on Feb 18, 2026, by an officer, for $904k. In total, from August 2025 through Nov 3, 2026: 0 purchases and 7 sales by directors, officers and large shareholders. All HCA insider trades →

Does HCA Healthcare pay a dividend?

Yes. Its dividend yield is 0.67% at the Nov 3, 2026 close (annual dividend of $3.12 per share). The next announced ex-dividend date is Dec 15, 2026.

What sector is HCA Healthcare in, and which index?

HCA Healthcare is classified in the Healthcare sector (industry: Medical Care Facilities), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →

What is behind these numbers

The concepts on this page, explained from scratch in the Academy. Free, no account.

The whole Academy, course by course →

Data as of Nov 3, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

The model portfolio, weekly in your inbox

Every Saturday, its week in one minute: how it went, the best and the worst, and which insiders bought with their own money. Plus, the day the model is rebuilt, which stocks come in and which go out. A simulation, not advice. At most one email a week, no ads, no account; one-click unsubscribe. Made by one person: Pol Gracia.

A model portfolio with simulated results, not a personalized recommendation. Your email is used for this only: privacy.

S&P 500 market gravity